- Home
- / UniPharma
UniPharma
Stock Price
NT$13.4
2024-10-29
Market Capitalization
NT$493.5 M
2024-10-29
Revenue
NT$88.4 M
FY, 2025
UniPharma Summary
Company Summary
- Overview
- UniPharma (单制药, also known as Huayu Pharmaceutical, 华宇药业) is a company that produces and distributes medical diagnoses, drugs, and equipment. It offers surgical sealants, injections, in vitro diagnostic reagents, antidotes, and other products.
- Type
- Public
- Status
- Active
- Founded
- 1998
- HQ
- TW | view all locations
- Website
- http://www.uni-pharma.com/
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Taipei City HQ
Taiwan
UniPharma Financials
Summary Financials
- Revenue (FY, 2025)
- NT$88.4M
- Gross profit (FY, 2025)
- NT$51.3M
- Net income (FY, 2025)
- (NT$40.5M)
- Cash (FY, 2025)
- NT$29.0M
- EBIT (FY, 2025)
- (NT$41.7M)
- Enterprise value
- $475.4M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026